Added to YB: 2025-10-01
Pitch date: 2025-09-29
KVUE [bullish]
Kenvue Inc.
+6.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America.
Market Cap
$33.2B
Pitch Price
$16.16
Price Target
N/A
Dividend
4.79%
EV/EBITDA
11.47
P/E
23.18
EV/Sales
2.74
Sector
Personal Care Products
Category
turnaround
Show full summary:
Kenvue (KVUE): Political Noise Creates a Buying Opportunity in a Consumer Health Leader
KVUE: Trump/RFK Jr. health comments drove stock to all-time lows despite no scientific evidence backing autism-Tylenol claims. Acetaminophen safety well-established over 132 years. Stock at 12x 2028 earnings, 46% discount to consumer staples peers (~17.5x). Recommend accumulating on weakness.
Read full article (1 min)